Outcomes based on timing of relapse. Outcomes after first isolated or combined relapses of B-lymphoblastic leukemia in children and adolescents treated in COG study AALL01P2. The overall 5-year EFS probabilities are depicted for very early, intermediate, and late medullary relapses (unpublished data).